secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2021-12-15T23:59:59+00:00
Accession:  0001493152-21-031504
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech appoints Roszell Mack III to Board effective January 1, 2022
---------------------------------------------------------------------------

- Board expanded from 7 to 8 directors; Mack fills newly created vacancy effective Jan 1, 2022.
- Mack is President of Mack & Co., LLC, with investment banking experience at Goldman Sachs and Salomon Smith Barney.
- Mack appointed to audit committee; eligible for annual restricted stock grants valued at $90,000.
- Executive Chairman Ron Nixon cites Mack's finance and venture scaling expertise as valuable to growth plans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315221031504/0001493152-21-031504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315221031504/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-031504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer